
GSK-2239633 is a мощный, селективный, allosteric CCR4 антагонист with pIC50 of 7.96; also inhibits TARC-induced increases in the F-actin content of isolated human CD4+ CCR4+ T-cells with pA2 of 7.1.
GSK-2239633 is a potent, selective, allosteric CCR4 antagonist with pIC50 of 7.96; also inhibits TARC-induced increases in the F-actin content of isolated human CD4+ CCR4+ T-cells with pA2 of 7.1.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.